You are here

Save the Date: May 11-12, 2017


A new research collaboration from scientists at the University at Buffalo and the Icahn School of Medicine at Mount Sinai identifies a role for Integrative Nuclear FGFR1 Signaling in schizophrenia...

Testing TGF-β inhibition as a radiosensitizer in tumor explants points toward a future of personalized therapies

Research from Jeremy Nance identifies cell cannibalism during development of C. elegans